"It is recognized that finally an individualized approach needs to be adopted and different MRI-directed biopsy strategies can be deployed. The key point is that prostate MRI and MRI-directed biopsy is a worthy first-line diagnostic strategy, backed up by systematic biopsy, used alone or as a supplement to target biopsy, depending on individual patient risk and patient preferences”
"The remote-controlled manipulator finally allows us to implement MRI guided prostate biopsies in our daily clinical routine. Despite little expertise in MR guided interventions, the training and support provided by Soteria Medical and the ease of use of the system quickly allowed us to do MR guided biopsies within 30 minutes. Soteria Medical delivers excellent and fast service and support and their personal contact has been very helpful during the learning process. The RCM allows us to deliver the best diagnostic tool for prostate cancer detection to our patients and clinical partners."
"The RCM is very much appreciated by patients referred to our radiology department for RCM-guided prostate biopsy. The majority of patients are surprised that they experience hardly any pain during or after the biopsy, and that it takes less than 30 minutes to finish the whole procedure. The pathologists are excited about the quality of the biopsy specimens. The software for positioning the needle is very intuitive which makes the RCM easy to work with resulting in a short individual learning curve."
The RCM allows us to achieve high precision biopsies in a time-efficient manner and with that it is greatly appreciated by our patients, clinicians and radiologists alike. Confident high precision biopsies reduce the number of unnecessary cores to a minimum and maximizes the chances of retrieving tissue representative of the patient’s disease. At the same time, it generates reliable feedback to the radiologist which we consider of paramount importance for optimizing the performance of the MR-diagnostics. Moreover, the efficiency of the procedure enables us to apply it whenever we expect it to outperform TRUS-biopsies, that is in most of our patients. With this, the system has revolutionized our practice and propelled us into a new era in the quest for stratifying prognosis.